2017-05-09T13:18:17-05:00 2016-12-31 341874260 CBIZ MHM LLC 700 WEST 47TH STREET SUITE 1100 KANSAS CITY MO 64112 990 2016-01-01 431889037 KANSAS CITY AREA LIFE SCIENCES INSTITUTE INC KANS 8167537700 30 W PERSHING ROAD NO 210 KANSAS CITY MO 64108 WAYNE O CARTER PRESIDENT 8167537700 2017-05-03 1 LISA BURKE P00220718 8169455500 4.15.200.102 2017-05-03 16:42:42 CD P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 686FD21B2BDCEC725286C8CE5A9B3BEB65EF5DF5 2016 2021-01-29 14:40:06Z WAYNE O CARTER 30 W PERSHING ROAD NO 210 KANSAS CITY MO 64108 1829587 0 X WWW.KCLIFESCIENCES.ORG X 2000 MO THE PURPOSE OF THIS ORGANIZATION IS TO PROMOTE AND FOSTER DEVELOPMENT OF LIFE SCIENCES IN THE KANSAS CITY METROPOLITAN AREA AND TO PROVIDE A PLATFORM FOR DEVELOPMENT AND COOPERATION IN THE AREA OF LIFE SCIENCES IN THE KANSAS CITY METROPOLITAN AREA. 12 11 6 52 0 0 1897646 1724324 101114 104363 88 900 0 0 1998848 1829587 337499 349863 0 0 651131 677307 0 0 102912 979073 343347 1967703 1370517 31145 459070 1555770 2014840 0 0 1555770 2014840 X THE PURPOSE OF THIS ORGANIZATION IS TO PROMOTE AND FOSTER DEVELOPMENT OF LIFE SCIENCES IN THE KANSAS CITY METROPOLITAN AREA AND TO PROVIDE A PLATFORM FOR DEVELOPMENT AND COOPERATION IN THE AREA OF LIFE SCIENCES IN THE KANSAS CITY METROPOLITAN AREA. 0 0 1032369 349863 104363 SEE SCHEDULE O 1032369 1 1 0 1 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 11 0 6 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 X 12 11 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 X X SHARON NEWMAN 8167537700 30 W PERSHING ROAD STE 210 KANSAS CITY MO 64108 IRVINE O HOCKADAY JR DIRECTOR 0.30 X 0 0 0 ROBERT A KIPP DIRECTOR & VICE CHAIRMAN 0.30 X 0 0 0 ANNE D ST PETER DIRECTOR 0.30 X 0 0 0 WILLIAM S BERKLEY DIRECTOR, CHAIRMAN 0.50 X 0 0 0 STEVEN ST PETER MD DIRECTOR 0.30 X 0 0 0 DONALD CRAIG BRATER DIRECTOR 0.10 X 0 0 0 STEPHEN REINTJES SECRETARY & TREASURER 0.25 X X 0 0 0 WAYNE O CARTER PRESIDENT 40.00 X X 259178 0 35175 DAVID FRANTZE DIRECTOR 0.30 X 0 0 0 ROBERT D REGNIER DIRECTOR 0.30 X 0 0 0 DEBORAH WILKERSON DIRECTOR 0.30 X 0 0 0 THOMAS SACK PHD DIRECTOR 0.30 X 0 0 0 KEITH A GARY VICE PRESIDENT 40.00 X 152068 0 25108 411246 0 60283 2 0 1 0 0 1724324 1724324 ANIMAL HEALTH SYMP. 900099 55763 55763 LIFE SCIENCES DINNER 900099 48600 48600 104363 900 900 1829587 104363 0 900 349863 349863 294353 147176 88306 58871 322023 249693 45374 26956 30684 12884 17048 752 30247 19719 6470 4058 21807 200 21607 44438 43839 499 100 23122 10988 8875 3259 17414 8274 9140 42629 17425 16288 8916 23663 21124 2539 9018 8981 37 4169 4169 ANNUAL MTG & LIFE SCI. 87085 87085 0 0 STEAM 18154 18154 0 0 MEMBERSHIPS AND DUES 15984 10430 5554 0 MISCELLANEOUS 10260 930 9330 0 25604 25604 1370517 1032369 235236 102912 23847 24249 1522602 1975333 125702 110444 9321 15258 1555770 2014840 0 0 X 1329770 1583840 226000 431000 1555770 2014840 1555770 2014840 459070 0 X 0 1 X 1 0 X X X 1 GREATER KC COMM FNDTN 431152398 8 1 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 2594 2594 1032369 1034963 178496 44624 0 0 200664 181272 231410 178496 791842 1187763 31535 1716 1707 2594 37552 50166 45318 57853 44624 197961 296942 49913 35754 14159 75789 74690 1099 15258 X 1829587 0 1829587 0 1829587 1370517 0 1370517 0 1370517 PART X, LINE 2: TAXES - KANSAS CITY AREA LIFE SCIENCES INSTITUTE, INC. HAS BEEN GRANTED AN EXEMPTION FROM INCOME TAXES BY THE INTERNAL REVENUE SERVICE UNDER THE PROVISIONS OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. THERE WAS NO UNRELATED BUSINESS INCOME DURING 2016 OR 2015 FOR THE ENTITY. THE INSTITUTE HAS EVALUATED THE STANDARDS REQUIRING DISCLOSURE OF UNCERTAIN TAX POSITIONS UNDER FASB ASC 740, INCOME TAXES, AND DETERMINED THAT THERE ARE NO MATERIAL MATTERS WHICH MERIT DISCLOSURE. 1 KU MEDICAL CENTER RESEARCH INSTITUTE INC 3901 RAINBOW BLVD KANSAS CITY KS 66160 481108830 501(C)(3) 149940 KCALSI-16-4 BKC UBOLRAT PIAMJARIYAKUL, PHD; KCALSI-16-5 PAUL PATTON TRUST GRANT: KATHY NEWELL; KCALSI-16-8 NEUROMUSCULOSKELETAL RESEARCH GRANT HIROSHI NISHIMUNE, PHD. CHILDREN'S MERCY HOSPITAL 2401 GILLHAM ROAD KANSAS CITY MO 64108 440605373 501(C)(3) 99924 KCALSI-16-2 BLUE KC OUTCOMES RESEARCH RUSSELL MCCULLOH, MD; KCALSI-16-1 BLUE KC OUTCOMES RESEARCH GRANT CY NADLER, PHD. MRIGLOBAL 425 VOLKER BLVD KANSAS CITY MO 64110 440645878 501(C)(3) 50000 KCALSI-16-7 PATTON TRUST RESEARCH GRANT CARL GELHAUS. UNIVERSITY OF MISSOURI KANSAS CITY 5100 ROCKHILL ROAD KANSAS CITY MO 64110 436003859 170(B)(1)(A)(II) 49999 KCALSI-16-6 PAUL PATTON TRUST RESEARCH GRANT JEFFREY GORSKI. 3 1 PART I, LINE 2: GRANTS ARE FOR A ONE YEAR DURATION. GRANT RECIPIENTS AGREE TO PROVIDE A PROGRESS REPORT AT SIX MONTHS AND A SUMMARY TECHNICAL PROGRESS REPORT WITHIN 30 DAYS OF THE END OF THE PERFORMANCE TO INCLUDE: 1. A BRIEF SUMMARY OF TECHNICAL PROGRESS RELATIVE TO THE GOALS AND OBJECTIVES PROPOSED IN THE PROPOSAL. 2. A BRIEF STATEMENT CONCERNING THE EFFECTIVENESS AND BENEFITS REALIZED FROM THE COLLABORATIONS INVOLVED. GRANT RECIPIENTS AGREE TO PROVIDE (UPON REQUEST) A COPY OF ALL PROPOSALS SUBMITTED TO EXTERNAL FUNDING AGENCIES AS A RESULT OF THE SUPPORT PROVIDED AND SUBSEQUENTLY NOTIFY KCALSI OF ACCEPTANCE OR REJECTION THEREOF. IF THE GRANT RECIPIENT RECEIVES ALTERNATIVE FUNDS FOR SUPPORT OF THIS SPECIFIC PROJECT, KCALSI REQUESTS THAT THE RECIPIENT RETURN ANY UNEXPENDED FUNDS TO THE INSTITUTE SO THAT THEY CAN BE USED TO SUPPORT OTHER INVESTIGATORS. X X X 0 0 0 0 0 0 0 0 0 WAYNE O CARTER PRESIDENT 259178 0 0 0 0 0 26035 0 9140 0 294353 0 0 0 KEITH A GARY VICE PRESIDENT 152068 0 0 0 0 0 15972 0 9136 0 177176 0 0 0 FORM 990, PART III, LINE 4A 2016 ACCOMPLISHMENTS: 1. REGIONAL LIFE SCIENCES STRATEGIC ASSESSMENT THE KANSAS CITY AREA LIFE SCIENCES INSTITUTE (KCALSI) ENGAGED DELOITTE TO EXECUTE A STRATEGIC ASSESSMENT OF THE REGIONAL LIFE SCIENCES IN 2015. THE PROCESS UTILIZED THE "COLLECTIVE IMPACT" MODEL FROM STANFORD UNIVERSITY AND WAS LED BY AN EXPERIENCED STEERING COMMITTEE COMPRISED OF COMMUNITY AND BUSINESS LEADERS IN THE LIFE SCIENCES. THE COMMITTEE LOOKED AT BOTH DRIVERS OF CLUSTER ENHANCEMENT AND REGIONAL SCIENTIFIC STRENGTHS. THE REGIONAL VISION DEVELOPED THROUGH THE ASSESSMENT PROCESS STATES, "THE KANSAS CITY REGION IS A GLOBAL LEADER AT THE NEXUS OF HUMAN AND ANIMAL HEALTH BENEFITING ALL OUR CITIZENS AND THE ECONOMY." THESE NEXUS OPPORTUNITIES WILL BE DIFFERENT FOR EACH STRATEGIC AREA AND WILL LIKELY RANGE FROM USING NATURALLY OCCURRING CANCER IN DOGS FOR ACCELERATING HUMAN DISCOVERIES TO ADVANCING OUR STRENGTH IN HEALTH IT AND OUTCOMES RESEARCH. FOUR AREAS OF SCIENTIFIC STRENGTH WERE IDENTIFIED: ANIMAL HEALTH, CANCER RESEARCH AND CARE, NEUROSCIENCE, AND HEALTH IT AND OUTCOMES RESEARCH. ADDITIONALLY, FOUR DRIVERS OF CLUSTER ENHANCEMENT WERE IDENTIFIED: COLLABORATION, WORKFORCE DEVELOPMENT, CAPITAL FORMATION, AND MESSAGING AND MARKETING. TASK FORCES WERE CREATED FOR EACH CLUSTER DRIVER AND WORK GROUPS FOR EACH SCIENTIFIC AREA. WE BELIEVE THE WORK OF THESE GROUPS WILL BE CRITICAL FOR THE SUCCESS OF OUR ENTIRE ECOSYSTEM AND ENABLE US TO BE MORE GLOBALLY COMPETITIVE. FY2016 PROGRESS IN SCIENTIFIC AREAS AND CLUSTER ENHANCEMENT DRIVERS IS DESCRIBED BELOW: - THE HEALTH IT AND OUTCOMES RESEARCH WORKING GROUP BEGAN DEVELOPING A PILOT PROJECT TO DEMONSTRATE THE IMPACT OF OUTCOMES RESEARCH ON QUALITY PATIENT CARE, IMPROVED PATIENT OUTCOMES, AND COST SAVINGS FOR PARTICIPATING HOSPITALS. - THE ANIMAL HEALTH WORKING GROUP IDENTIFIED OPPORTUNITIES TO DEVELOP A PROOF OF CONCEPT FUND AND INTERCONNECT LARGE ANIMAL HEALTH DATABASES WITH THE HUMAN HEALTH DATABASES TO ACCELERATE DRUG DEVELOPMENT - THE CANCER RESEARCH AND CARE WORKING GROUP BEGAN EXPLORING WAYS TO ENHANCE COMMUNICATIONS AND TRIALS BETWEEN HUMAN CANCER PHYSICIANS AND VETERINARY ONCOLOGISTS TO ACCELERATE RESEARCH AND CARE FOR BOTH HUMANS AND ANIMALS - THE NEUROSCIENCES WORKING GROUP EVALUATED FEDERAL FUNDING TO IDENTIFY COMPETITIVE NEUROSCIENCE RESEARCH STRENGTHS AND DIVIDED INTO SUBCOMMITTEES: ONE FOCUSED ON NEURODEVELOPMENTAL DISEASES, AND ONE ON FOCUSED ON NEURODEGENERATIVE DISEASES - THE COLLABORATION TASK FORCE LED BY DR. MARC HAHN, PRESIDENT AND CEO OF KANSAS CITY UNIVERSITY, RECOGNIZED THE IMPORTANCE OF OUR REGIONAL INSTITUTIONS WORKING TOGETHER. THE WORKING GROUP DRAFTED THIS STATEMENT THAT WAS SUBSEQUENTLY SIGNED BY OUR REGIONAL LIFE SCIENCE INSTITUTION CHANCELLORS AND CEOS ACKNOWLEDGING THE VALUE AND IMPORTANCE OF COLLABORATION. THIS IS THE FIRST TIME SUCH A STATEMENT HAS BEEN APPROVED. COLLABORATION IN OUR REGION IS CRITICAL AS OUR RELATIVE SIZE REQUIRES THAT ESTABLISHMENTS WORK TOGETHER IF WE ARE GOING TO BE COMPETITIVE WITH OTHER PARTS OF THE COUNTRY AND GLOBE. 2. COLLABORATE2CURE KCALSI CREATED A COLLABORATE2CURE EVENT WITH THE GOAL OF STIMULATING REGIONAL SCIENTIFIC COLLABORATION AND DEVELOPING INNOVATIVE WAYS TO SOLVE SCIENTIFIC CHALLENGES. THE GOAL OF THIS COLLABORATE2CURE EVENT WAS TO PROVIDE A PLATFORM FOR COLLABORATION, ALLOWING SCIENTISTS IN THE KC REGION TO SHARE THEIR RESEARCH AND ULTIMATELY COMPETE FOR FUNDING DOLLARS. THE SESSIONS OCCUR WEEKLY AND ATTENDEES WERE ABLE TO PARTICIPATE IN-PERSON OR LIVE VIA WEBCASTING. EACH SESSION WAS FOLLOWED BY A NETWORKING OPPORTUNITY. OVER 300 SCIENTISTS, CLINICIANS, ENTREPRENEURS AND STUDENTS GATHERED OVER THIS 12-WEEK PERIOD TO GAIN AND SHARE KNOWLEDGE SURROUNDING CANCER IMMUNOTHERAPY. THE TOPIC WAS SELECTED FOR THE FIRST SCIENTIFIC SERIES CHAIRED BY DR. DOUG MYERS FROM CHILDREN'S MERCY. THIS FAST-PACED, EVOLVING FIELD OF SCIENTIFIC RESEARCH IS CREATING SEVERAL NEW METHODS FOR DIAGNOSING AND TREATING CANCER, AND WAS AN IDEAL TOPIC FOR THE FIRST COLLABORATE2CURE SERIES. AN ONLINE PORTAL WAS ALSO CREATED FOR SCIENTISTS TO SHARE IDEAS, ARTICLES, PUBLICATIONS AND VIDEOS FROM THE COLLABORATE2CURE SESSIONS. EVERY SCIENTIST WHO PRESENTED AT THE COLLABORATE2CURE EVENT WAS ASKED THE FOLLOWING QUESTIONS: 1) WHAT PROBLEM ARE YOU TRYING TO SOLVE? 2) WHAT UNIQUE APPROACH/TECHNOLOGY ARE YOU APPLYING TO THE PROBLEM? 3) WHAT RESULTS HAVE YOU COLLECTED? 4) WHAT TYPES OF COLLABORATION MIGHT YOU BE INTERESTED IN DEVELOPING? 5) WHAT PROBLEMS DO YOU NEED SOLVED? AT THE CONCLUSION OF THE CANCER IMMUNOTHERAPY COLLABORATE2CURE SERIES, A REQUEST FOR PROPOSALS WAS RELEASED TO SUPPORT COLLABORATIVE, INNOVATIVE, RESEARCH PROJECTS SPAWNED FROM THE DISCUSSIONS AT A FUNDING LEVEL OF $50,000 FOR UP TO ONE YEAR. 3. WORKFORCE DEVELOPMENT WORKFORCE DEVELOPMENT WAS IDENTIFIED IN KCALSL'S PATH TO 2025 REPORT AS A SIGNIFICANT THREAT AND CRITICAL WEAKNESS TO THE REGIONAL LIFE SCIENCE CLUSTER. KC RISING, A CIVIC INITIATIVE UNDERWAY ACROSS THE KANSAS CITY COMMUNITY, ESTABLISHED A HUMAN CAPITAL WORK GROUP TO ADDRESS WORKFORCE DEVELOPMENT ISSUES. RECOGNIZING THE OPPORTUNITY TO LEVERAGE A PARALLEL EFFORT, KCALSI INTEGRATED ITS EFFORTS AND EXPERTISE WITH KC RISING TO DEVELOP A REGIONAL PLAN OF ACTION. DARYL PINT, CHIEF EXECUTIVE OFFICER OF CEVA BIOMUNE AND KEITH GARY, KCALSI VICE PRESIDENT CO-CHAIRED THE SCIENCE TECHNOLOGY ENGINEERING AND MATHEMATICS (STEM)/LIFE SCIENCES SUBCOMMITTEE THAT WAS COMPRISED OF REPRESENTATIVES FROM K-12 EDUCATION, HIGHER EDUCATION, STEM ORGANIZATIONS, LIFE SCIENCE STAFFING ORGANIZATIONS, AND INDUSTRY LEADERS. THE INITIAL PHASE OF THE WORK IDENTIFIED SEVERAL STRATEGIES FOR POSITIVELY IMPACTING WORKFORCE DEVELOPMENT INCLUDING: - EXPANDED USE OF NATIONAL CAREER READINESS CREDENTIALS IN KC RISING'S TARGET INDUSTRIES. - EXPANDING TEACHER EXTERNSHIP OPPORTUNITIES IN THE LIFE SCIENCES INDUSTRY. - BUILDING STACKABLE CREDENTIALS THAT LEAD TO STEM DEGREES. - GUIDELINES FOR EFFECTIVE STEM EDUCATION AT THE K-12 LEVEL. THE COMBINED KCALSI/KC RISING HUMAN CAPITAL EFFORT HAS MOVED INTO A SECOND PROJECT PHASE THAT USES TALENT TO INDUSTRY EXCHANGES (TIE) TO IDENTIFY AND DEVELOP INDUSTRY-SPECIFIC WORKFORCE DEVELOPMENT SOLUTIONS. THE LIFE SCIENCES INDUSTRY WAS SELECTED AS THE FIRST KANSAS CITY USE OF THE TIE PROCESS. A WRITTEN REPORT WITH SPECIFIC RECOMMENDATIONS FOR ADDRESSING LIFE SCIENCES WORKFORCE ISSUES WILL BE RELEASED IN EARLY 2017. THE NEED FOR GREATER HIGH SCHOOL ENGAGEMENT WAS REITERATED IN THE PATH TO 2025 BECAUSE OF THE REGION'S WEAKNESS IN NATIONAL ADVANCED PLACEMENT SCORES IN MATH AND SCIENCE. IN 2016, KCALSI SUPPORTED MANY STEM AREAS INCLUDING BIOGENEIUS, THE ONLY INTERNATIONAL COMPETITIVE SCIENCE PROGRAM FOR HIGH SCHOOL STUDENTS. KCALSI FUNDED AND SUPPORTED A K-12 PROGRAM ENGAGING OVER 600 STUDENTS FROM LANSING MIDDLE SCHOOL TO DESIGN AN EXPERIMENT THAT WAS FLOWN ON MISSION 10 TO THE INTERNATIONAL SPACE STATION. FORM 990, PART III, LINE 4A (CONTINUED) 4. KCALSI'S RESEARCH DEVELOPMENT GRANT PROGRAMS THE KCALSI RESEARCH DEVELOPMENT GRANTS PROGRAM REPRESENTS ONE OUR OLDEST AND MOST POPULAR PROGRAMS. GRANTS ARE AWARDED TO GENERATE PRELIMINARY DATA THAT SUPPORT SUBMISSION OF MAJOR MULTIDISCIPLINARY RESEARCH PROPOSALS TO GOVERNMENT OR PRIVATE FUNDING AGENCIES. APPLICANTS RECEIVE WRITTEN PEER REVIEWS, REGARDLESS OF WHETHER THEIR PROJECT RECEIVED FUNDING, TO HELP THEM IMPROVE FUTURE GRANT APPLICATIONS. THIS IS A VALUED SERVICE APPRECIATED BY ALL TEN STAKEHOLDERS. FROM 2007 TO 2015, KCALSI HAS MANAGED 69 GRANTS TOTALING $3,300,144. ON AVERAGE, FOR EVERY $1 INVESTED IN GRANTS, $9.10 HAS BEEN RETURNED TO THE REGION FROM FOLLOW-ON FEDERAL SOURCES. IMPORTANTLY, THIS NUMBER SHOULD BE VIEWED CONSERVATIVELY AS NO INFORMATION IS READILY AVAILABLE REGARDING GRANTS MADE TO REGIONAL SCIENTISTS BY PRIVATE FOUNDATIONS AND PATIENT ADVOCACY ORGANIZATIONS. THE 2016 KCALSI RESEARCH DEVELOPMENT PROGRAM GRANT IS AS FOLLOWS: BLUE KC OUTCOMES RESEARCH GRANTS FOCUS ON IMPROVING THE QUALITY OF THE HEALTHCARE PROCESS, REDUCING COSTS, IMPROVING EFFECTIVENESS OR EFFICIENCY OF THE HEALTHCARE PROCESS, AND/OR IMPROVING ACCESS TO HEALTHCARE. PARTNERING WITH BLUE CROSS AND BLUE SHIELD OF KANSAS CITY, KCALSI AWARDED FOUR GRANTS OF UP TO $50,000 EACH IN MAY 2016. THE GRANTS WERE PRESENTED TO FOUR RESEARCH SCIENTISTS, TWO AT CHILDREN'S MERCY HOSPITAL, ONE AT SAINT LUKE'S HOSPITAL AND ONE AT THE UNIVERSITY OF KANSAS MEDICAL CENTER. PAUL PATTON CHARITABLE TRUST GRANTS FOCUS ON THE GENETIC BASIS OF DISEASES THAT AFFECT CHILDREN. THE FUNDS FOR THIS PROGRAM ARE PROVIDED BY THE PAUL PATTON TRUST, TED C. MCCARTER, WILLIAM EVANS JR. AND BANK OF AMERICA, N.A., TRUSTEE. KCALSI AWARDED GRANTS OF UP TO $50,000 TO THREE RESEARCHERS, ONE EACH TO MRIGLOBAL, UNIVERSITY OF MISSOURI-KANSAS CITY, AND UNIVERSITY OF KANSAS MEDICAL CENTER. NEUROMUSCULOSKELETAL GRANT TARGETS REGIONAL RESEARCH EXPERTISE FOCUSED ON NEUROMUSCULOSKELETAL DISEASES, SUCH AS AMYOTROPHIC LATERAL SCLEROSIS OR MULTIPLE SCLEROSIS. IN 2016 THE VICTOR E. SPEAS FOUNDATION TRUST, BANK OF AMERICA N.A., TRUSTEE PROVIDED FUNDS FOR ONE $50,000 GRANT THAT WAS AWARDED TO A RESEARCH SCIENTIST AT THE UNIVERSITY OF KANSAS MEDICAL CENTER. 5. 2016 ANNUAL DINNER AND "SCIENCE OF ART" AUCTION OVER 450 ATTENDED THE KCALSI ANNUAL DINNER AND ENJOYED KEYNOTE SPEAKER DR. ATUL BUTTE'S PRESENTATION, TRANSLATING A TRILLION POINTS OF DATA INTO THERAPIES, DIAGNOSTICS, AND NEW INSIGHTS INTO DISEASE. ATUL BUTTE, MD, PHD IS THE INAUGURAL DIRECTOR OF THE INSTITUTE OF COMPUTATIONAL HEALTH SCIENCES AT THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, AND A PROFESSOR OF PEDIATRICS. HE ALSO SERVES AS THE EXECUTIVE DIRECTOR FOR CLINICAL INFORMATICS ACROSS SIX UNIVERSITY OF CALIFORNIA MEDICAL SCHOOLS AND MEDICAL CENTERS. DR. BUTTE'S FULL PRESENTATION CAN BE VIEWED AT WWW.KCLIFESCIENCES.ORG/VIDEO CATEQORY/EVENT_SPEAKERS 6. ONE HEALTH INNOVATIONS SYMPOSIUM THE 2016 ONE HEALTH INNOVATIONS SYMPOSIUM: THE NEXUS OF HUMAN AND ANIMAL MEDICINE SYMPOSIUM WAS HELD IN AUGUST 28 TO 29 AT THE KANSAS CITY CONVENTION CENTER. KCALSI COORDINATED THIS TWO-DAY EVENT ALONG WITH THE UNIVERSITY OF MISSOURI, KANSAS STATE UNIVERSITY AND INDUSTRY PARTNERS. THE GOAL WAS TO HIGHLIGHT THE OPPORTUNITIES IN COMPARATIVE AND TRANSLATIONAL RESEARCH. THE MEETING WAS DESIGNED TO STRETCH SCIENTISTS, PHYSICIANS AND VETERINARIANS TO THINK ABOUT DISEASES OCCURRING IN BOTH HUMANS AND COMPANION ANIMALS COMPARING CELLULAR, GENETIC AND DISEASE PROCESSES ACROSS SPECIES. THE FOCUS WAS ON NATURALLY OCCURRING DISEASES IN COMPANION ANIMALS THAT CREATE RESEARCH OPPORTUNITIES FOR IDENTIFYING MEDICAL RESEARCH BREAKTHROUGHS BENEFITING BOTH PETS AND PEOPLE. EACH TOPIC WAS PRESENTED BY THREE SPEAKERS PROVIDING HUMAN, ANIMAL AND REGULATORY PERSPECTIVES. THE TOPICS COVERED BY 36 SPEAKERS INCLUDED: - GENE THERAPY - MELANOMA - OSTEOSARCOMA VACCINE - LISTERIA MONOCYTOGENES - ORTHOPEDICS - BIG DATA- OUTCOMES - GENE THERAPY- DUCHENNE MUSCULAR DYSTROPHY - POLYCYSTIC KIDNEY DISEASE - WHARTON JELLY - STEM CELL - DIABETES - ISLET CELL TRANSPLANT THE SYMPOSIUM FEATURED TWO KEYNOTE SPEAKERS: ONE HEALTH ADVANCES AND SUCCESSES IN COMPARATIVE MEDICINE AND TRANSLATIONAL RESEARCH BY CHERYL STROUD, DVM, PHD, EXECUTIVE DIRECTOR, ONE HEALTH COMMISSION, AND COMPARATIVE ONCOLOGY: ONE HEALTH IN ACTION, BY AMY K. LEBLANC, DVM, DACVIM, DIRECTOR, COMPARATIVE ONCOLOGY PROGRAM, CENTER FOR CANCER RESEARCH, NATIONAL CANCER INSTITUTE. 7. REGIONAL TRANSLATIONAL MEDICINE MEETING KCALSI WORKED WITH SAINT LUKE'S HOSPITAL AND THE UNIVERSITY OF MISSOURI - KANSAS CITY TO ORGANIZE THE FOURTH ANNUAL TRANSLATIONAL MEDICINE MEETING ON APRIL 21 AND 22. THE GOAL OF THIS MEETING WAS TO STIMULATE NEW COLLABORATIONS ACROSS THE REGION BETWEEN OUR ACADEMIC INSTITUTIONS AND WITH INDUSTRY. THE PREVIOUS THREE MEETINGS WERE HELD IN COLUMBIA AT THE UNIVERSITY OF MISSOURI (2013), IN MANHATTAN AT KANSAS STATE UNIVERSITY (2014), AND IN LAWRENCE AT THE UNIVERSITY OF KANSAS (2015). ON APRIL 21, THE MEETING INCLUDED PRESENTATIONS FROM DR. LYNDA BONEWALD ON MUSCULOSKELETAL DISEASES, DR. PETER KOULEN ON NOVEL WAYS TO DIAGNOSE CHRONIC DISEASES AND DR. JERRY WYCKOFF ON IN SILICO DRUG DISCOVERY APPROACHES. THERE WERE ALSO PRESENTATIONS ON NEW CANCER APPROACHES AND A NOVEL METHOD FOR INSULIN ADMINISTRATION USING LIGHT. THE DAY WAS COMPLETED BY A PRESENTATION FROM MARIA MEYERS AND JIM BAXENDALE DISCUSSING KANSAS CITY'S ENTREPRENEURIAL ECOSYSTEM. ON FRIDAY APRIL 22, THE PRESENTATIONS WERE HOSTED BY SAINT LUKE'S HOSPITAL WITH INTERNATIONALLY RENOWNED CARDIOLOGIST DR. JOHN SPERTUS PRESENTING THE VISION OF TRANSLATIONAL MEDICINE IN CLINICAL CARE. PRESENTATIONS CONTINUED BY DR. JAMES CASE ON IMPROVING THE ACCURACY OF DIAGNOSTIC TESTING AND EVALUATING THE COST EFFECTIVENESS OF NOVEL INTERVENTIONS BY DR. DAVID COHEN. ADDITIONAL PRESENTATIONS INCLUDED PRECISION MEDICINE, AND SHARED DECISION MAKING TOOLS IN OUTCOMES RESEARCH AND PROVIDED A CONTINUUM OF OPPORTUNITY FOR UTILIZING OUTCOMES RESEARCH IN CLINICAL STUDIES. THE AGENDA DEVELOPMENT FOR THE TWO-DAY, TWO-VENUE EVENT WAS LED BY DRS. LAWRENCE DREYFUS AND JOHN SPERTUS WHO PUT TOGETHER AN EXCELLENT AGENDA SHOWCASING AREAS OF TRANSLATIONAL MEDICINE AT THE UNIVERSITY OF MISSOURI-KANSAS CITY AND SAINT LUKE'S HEALTH SYSTEM. 8. MEDICAL DEVICE NETWORK OF KANSAS CITY THE MEDICAL DEVICE NETWORK - KANSAS CITY (MDN) HAS ESTABLISHED A RECOGNIZABLE PRESENCE IN THE LARGER LIFE SCIENCES COMMUNITY OVER THE PAST FOUR YEARS. KCALSI MANAGES AND FACILITATES MDN AND THE MDNKC.COM WEBSITE. THE MDN'S QUARTERLY MEETINGS PROVIDE A VENUE FOR MEMBERS TO BENEFIT FROM BEST PRACTICE STANDARDS AND OFFER ACADEMIC STUDENTS AN OPPORTUNITY TO EXPLORE CAREER OPPORTUNITIES IN THE MEDICAL DEVICE ARENA. THE 2016 MDN MEETINGS FEATURED TOPICS INCLUDING REGULATORY ISSUES, INTELLECTUAL PROPERTY, REGIONAL ENTREPRENEURSHIP VIBRANCY, CAPITAL FORMATION, FACULTY START-UPS AND COMMERCIALIZATION. MDN CONCLUDED 2016 UNDER THE GUIDANCE OF DR. IVAN BROWN, CEO OF BROWNMED. THE MDN MEMBERSHIP APPROVED A NEW CHAIR STEVE POPE, CHIEF EXECUTIVE OFFICER AND FOUNDER OF R2FACT PRODUCT DEVELOPMENT. MR. POPE RECEIVED AN MS IN INDUSTRIAL DESIGN FROM THE GEORGIA INSTITUTE FOR TECHNOLOGY AND BFA IN INDUSTRIAL DESIGN FROM THE UNIVERSITY OF KANSAS. FORM 990, PART III, LINE 4A (CONTINUED) 9. LIFE SCIENCES INDUSTRY CENSUS KCALSI HAS TRACKED THE REGION'S LIFE SCIENCES COMPANY INVENTORY SINCE 2003. CONDUCTED EVERY THREE YEARS, REPORTS HAVE BEEN PUBLISHED IN 2003, 2006, 2009, AND 2012. THE LIFE SCIENCES INDUSTRY CENSUS IS THE ONLY SYSTEMATIC ASSESSMENT OF INDUSTRY ASSETS IN THE REGION THAT IS REPEATED EVERY THREE YEARS. THE CENSUS COLLECTS WORKFORCE DATA THAT PROVIDES IMPORTANT INFORMATION FOR INSTITUTIONS ACROSS THE EDUCATIONAL CONTINUUM REGARDING INDUSTRY NEEDS. THE LIFE SCIENCES CENSUS IS AN INVALUABLE TOOL SHARED WITH BUSINESS AND CIVIC LEADERS, LEGISLATORS, ECONOMIC DEVELOPERS, AND MANY OTHERS. THE 2015 LIFE SCIENCES INDUSTRY CENSUS WAS RELEASED IN JANUARY OF 2016, AND BESIDES THE PRINTED VERSION HANDED OUT AT MULTIPLE MEETINGS, THE ONLINE VERSION OF THE 2015 INDUSTRY CENSUS WAS DOWNLOADED 145 TIMES IN 2016. ACCORDING TO THE 2015 LIFE SCIENCES INDUSTRY CENSUS THE NUMBER OF LIFE SCIENCE COMPANIES IN THE REGION GREW TO 250, AN INCREASE OF TEN COMPANIES, WITH EMPLOYMENT GROWTH OF OVER 20 PERCENT FOR THE REGION SINCE 2012. THE STUDY FOUND THE MAJORITY OF LIFE SCIENCES COMPANIES ARE CONCENTRATED IN THE IMMEDIATE KANSAS CITY METROPOLITAN AREA, WITH 56 PERCENT OF THE COMPANIES LOCATED IN JACKSON COUNTY, MISSOURI, AND JOHNSON COUNTY, KANSAS. WHEN ASKED ABOUT FUTURE HIRING, 91 PERCENT OF RESPONDENTS INDICATED PLANS TO ADD EMPLOYEES IN THE NEXT 36 MONTHS AND NO RESPONDENTS PROJECTED STAFFING CUTS. ANALYZING THE INDUSTRY OVER THE PAST NINE YEARS REVEALS CONSISTENT GROWTH IN THE NUMBER OF COMPANIES AND OVERALL EMPLOYMENT IN THE LIFE SCIENCES INDUSTRY IN THE REGION. THE REGION HAS GROWN FROM 199 LIFE SCIENCES COMPANIES EMPLOYING BETWEEN 17,500 TO 20,000 PEOPLE AS IDENTIFIED IN THE 2006 CENSUS TO 250 COMPANIES EMPLOYING BETWEEN 28,000 TO 30,000 PEOPLE AS IDENTIFIED IN THE 2015 CENSUS. THE ACTUAL GROWTH RATES ARE MARKEDLY HIGHER TO SUSTAIN GROWTH IN THE FACE OF CONSOLIDATION IN THE ANIMAL HEALTH AND HUMAN PHARMACEUTICAL INDUSTRIES. FORM 990, PART VI, SECTION A, LINE 2 ANNE D. ST. PETER AND STEVEN ST. PETER,MD HAVE A FAMILY RELATIONSHIP. FORM 990, PART VI, SECTION B, LINE 11B THE ORGANIZATION HAS A POLICY FOR THE ORGANIZATION'S AUDIT COMMITTEE TO REVIEW THE 990 BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C ALL STAFF AND DIRECTORS MUST SUBMIT ANY CONFLICTS OF INTEREST ON AN ANNUAL BASIS. IF A CONFLICT ARISES WITHIN THE BOARD, THE DISCLOSING INDIVIDUAL SHALL NEITHER VOTE NOR ENDEAVOR TO INFLUENCE THE DECISION. FORM 990, PART VI, SECTION B, LINE 15A COMPENSATION OF THE ORGANIZATION'S PRESIDENT IS AGREED UPON BY THE BOARD OF DIRECTORS AND FINALIZED VIA A WRITTEN EMPLOYMENT CONTRACT. THIS APPROVAL IS DOCUMENTED IN THE MINUTES OF THE BOARD. IN 2013 THE ORGANIZATION CREATED A COMPENSATION COMMITTEE AND CONDUCTED A COMPENSATION STUDY TO FURTHER REFINE THE COMPENSATION PROCESS. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE ONLY AVAILABLE UPON REQUEST. KC BIO HOLDINGS INC 30 W PERSHING ROAD STE 210 KANSAS CITY MO 64108 412115941 LIFE SCIENCES MO N/A C 1.00000 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0